Viyash Scientific Limited
Ashoka WhiteOak trimmed its stake in Viyash Scientific from 2.14% to 0.14%, selling 87,47,392 shares via the open market.
A leading animal health company headquartered in India, this organization develops and manufactures finished dose formulations, active pharmaceutical ingredients, and analytical services for the pharmaceutical and life sciences sectors. Operating across more than 100 countries spanning five continents, the company serves veterinary and industrial clients globally with a comprehensive product portfolio designed for animal health applications and therapeutic solutions.
India equity vehicle of WhiteOak Capital, the Singapore-headquartered manager founded in 2017 by Prashant Khemka, former CIO of Goldman Sachs Asset Management's India Equity and Global Emerging Markets businesses. WhiteOak group manages USD 10.8 bn (~Rs 96,000 cr) across SMAs and funds. Ashoka India Opportunities Fund ranks as the best-performing India UCITS fund since 2018 inception.